BackFiore Cannabis Overview

Fiore Cannabis EBIT

Track Fiore Cannabis's EBIT ($-5.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$1.07M
↑ 43.41% YoY

As of Jun 30, 2022

Annual EBIT (TTM)

-$5.35M
↑ 34.08% YoY

Trailing 12 months ending Jun 30, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Fiore Cannabis (FIORF) FAQ

The latest EBIT for FIORF is $-5.4M as of June 2022. That compares with $-8.1M in the prior-year period — up 34.1% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside Fiore Cannabis's historical trend and sector peers before judging valuation or financial health.

Over the past year, FIORF's EBIT moved from $-8.1M to $-5.4M — a 34.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fiore Cannabis's operating scale or balance-sheet position.

Against its sector companies, FIORF currently prints $-5.4M for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Fiore Cannabis's growth, margins, and balance sheet.

A EBIT figure of $-5.4M for FIORF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting FIORF's EBIT ($-5.4M), review year-over-year change from $-8.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.